// App-Quantinova.ai

609 : Molecular subtyping of pancreatic adenocarcinoma identifies SV2 positive subpopulation in classical PDAC

Researchers

Presenter

  • Daniela Dias-Santos

Principal Investigators

  • Matteo Ligorio

  • Kshitij Arora

  • Vishal Thapar

  • Olivia C. MacKenzie

  • Srinjoy Sil

  • Niyati Desai

  • Vikram Deshpande

  • Miguel N. Rivera

  • Cristina R. Ferrone

  • David T. Ting

Medical Centers

  • Massachusetts General Hospital Cancer Center, Department of Medicine, Chronic Diseases Research Center, Nova Medical School, Boston, MA

  • Massachusetts General Hospital Cancer Center, Department of Surgery and Department of Pathology, Boston, MA

  • Massachusetts General Hospital Cancer Center, Department of Pathology, Boston, MA

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Massachusetts General Hospital Cancer Center, Department of Pathology, Boston, MA

  • Massachusetts General Hospital Cancer Center, Department of Pathology, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Aldehyde dehydrogenase 1

  • Circulating tumor cells

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved